Scribd Logo
Upload

Welcome to Scribd!

  • Omprakashreport

    Uploaded by

    Veeraj Singh
    5 views1 page
    Mr. Om Prakash, age 31, tested positive for COVID-19 via a nasopharyngeal and oropharyngeal swab sample collected on June 22, 2022. The TrueNat test detected SARS-CoV-2 RNA in both the E gene and ORF1a gene, with CT values of 14.0 and 14.5 respectively, confirming a positive result for COVID-19. The TrueNat test uses real-time reverse transcription polymerase chain reaction (RT-PCR) to specifically amplify target regions of the virus to detect its presence.

    Original Description:

    Original Title

    omprakashreport (1) (3) (2)

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Mr. Om Prakash, age 31, tested positive for COVID-19 via a nasopharyngeal and oropharyngeal swab sample collected on June 22, 2022. The TrueNat test detected SARS-CoV-2 RNA in both the E gene and ORF1a gene, with CT values of 14.0 and 14.5 respectively, confirming a positive result for COVID-19. The TrueNat test uses real-time reverse transcription polymerase chain reaction (RT-PCR) to specifically amplify target regions of the virus to detect its presence.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    5 views1 page

    Omprakashreport

    Uploaded by

    Veeraj Singh
    Mr. Om Prakash, age 31, tested positive for COVID-19 via a nasopharyngeal and oropharyngeal swab sample collected on June 22, 2022. The TrueNat test detected SARS-CoV-2 RNA in both the E gene and ORF1a gene, with CT values of 14.0 and 14.5 respectively, confirming a positive result for COVID-19. The TrueNat test uses real-time reverse transcription polymerase chain reaction (RT-PCR) to specifically amplify target regions of the virus to detect its presence.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    TEST REPORT

    Patient Name : MR. OM PRAKASH Sample Collected Date : 22/06/2022, 08:00 AM


    Age / Sex : 31 years / Male Sample Reporting Date : 22/06/2022, 01:53 PM
    Sample ID : 222020065 Patient ID : 214851
    Ref. By : SELF Mobile No. :

    Test Name Observed Values


    MOLECULAR BIOLOGY
    COVID -19 BY TRUENAT

    IDENTITY NUMBER V6773661 D.O.B 10/06/1991

    SRF ID 3460000961850

    ICMR ID 756190463

    TYPE OF SAMPLE NASOPHARYNGEAL & OROPHARYNGEAL

    SARS COVID-19 POSITIVE - HIGH

    BETA COV (E GENE)


    POSITIVE
    Method: REAL TIME PCR

    CT Value (E GENE) 14.0

    ORF1a (GENE)
    POSITIVE
    Method: REAL TIME PCR

    CT Value (ORF1a) 14.5

    ICMR REGISTRATION NUMBER COVID 19 - ACLAAXRMP


    Technology:
    Truenat tests works on the principle of Real Time Reverse Transcription Polymerase Chain Reaction(Real time PCR). It involves the specific amplification of target region. This analysis is done on (Truelab real

    time PCR by using the sensitive and specific Taqman assay method. Amplified products are indicated bythreshold cycle (Ct) in amplification curve. The Performance of this test is been Validated and

    Evaluated by ICMR & has been recommended by ICMR for Screening & Confirmation of COVID-19 Target Selection: The target sequence used for Truenat Beta CoV is E gene of Sarbeco virus, and

    that for SARS CoV-2 is E & ORF1a gene. Human RNase P gene serves as a full process internal control (IPC) for proper swab collection, nucleic acid extraction and PCR in both tests

    Interpretation

    RESULT REMARKS

    POSITIVE : RNA SPECIFIC TO SARS-COV2- DETECTED

    NEGATIVE : RNA SPECIFIC TO SARS-COV2- NOT DETECTED

    **END OF REPORT**

    Page 1 of 1

    You might also like